← The SEC Ephemeris: the whole map
Sun Pharma Global FZE Levetiracetam
In the graph: all 1 documents (3 pages).
- Application
- NDA 204417
- Ticker
- Sun Pharma Global FZE
- Product
- Levetiracetam
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- March 29, 2013
From FDA letters and SEC filings. Not investment or medical advice.